Evidence map›Paper›PMID 41024005›Full record

ArticleBMC medical informatics and decision making2025

Ethical implications of using general-purpose LLMs in clinical settings: a comparative analysis of prompt engineering strategies and their impact on patient safety.

Pouyan Esmaeilzadeh

Abstract readComparative Study
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pouyan EsmaeilzadehDepartment of Information Systems and Business Analytics, College of Business, Florida International University (FIU), Modesto A. Maidique Campus, 11200 S.W. 8th St, RB 261B, Miami, FL, 33199, USA. pesmaeil@fiu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rapid integration of large language models (LLMs) into healthcare raises critical ethical concerns regarding patient safety, reliability, transparency, and equitable care delivery. Despite not being trained explicitly on medical data, individuals increasingly use general-purpose LLMs to address medical questions and clinical scenarios. While prompt engineering can optimize LLM performance, its ethical implications for clinical decision-making remain underexplored. This study aimed to evaluate the ethical dimensions of prompt engineering strategies in the clinical applications of LLMs, focusing on safety, bias, transparency, and their implications for the responsible implementation of AI in healthcare.

methodsWe conducted an ethics-focused analysis of three advanced and reasoning-capable LLMs (OpenAI O3, Claude Sonnet 4, Google Gemini 2.5 Pro) across six prompt engineering strategies and five clinical scenarios of varying ethical complexity. Six expert clinicians evaluated 90 responses using domains that included diagnostic accuracy, safety assessment, communication, empathy, and ethical reasoning. We specifically analyzed safety incidents, bias patterns, and transparency of reasoning processes.

resultsSignificant ethical concerns emerged across all models and scenarios. Critical safety issues occurred in 12.2% of responses, with concentration in complex ethical scenarios (Level 5: 23.1% vs. Level 1: 2.3%, p < 0.001). Meta-cognitive prompting demonstrated superior ethical reasoning (mean ethics score: 78.3 ± 9.1), while safety-first prompting reduced safety incidents by 45% compared to zero-shot approaches (8.9% vs. 16.2%). However, all models showed concerning deficits in communication empathy (mean 54% of maximum) and exhibited potential bias in complex multi-cultural scenarios. Transparency varied significantly by prompt strategy, with meta-cognitive approaches providing the clearest reasoning pathways (4.2 vs. 1.8 explicit reasoning steps), which are essential for clinical accountability. The study highlighted critical gaps in ethical decision-making transparency, with meta-cognitive approaches providing 4.2 explicit reasoning steps compared to 1.8 in zero-shot methods (p < 0.001). Bias patterns disproportionately affected vulnerable populations, with systematic underestimation of treatment appropriateness in elderly patients and inadequate cultural considerations in end-of-life scenarios.

conclusionsCurrent clinical applications of general-purpose LLMs present substantial ethical challenges requiring urgent attention. While structured prompt engineering demonstrated measurable improvements in some domains, with meta-cognitive approaches showing 13.0% performance gains and safety-first prompting reducing critical incidents by 45%, substantial limitations persist across all strategies. Even optimized approaches achieved inadequate performance in communication and empathy (≤ 54% of maximum), retained residual bias patterns (11.7% in safety-first conditions), and exhibited concerning safety deficits, indicating that current prompt engineering methods provide only marginal improvements, which are insufficient for reliable clinical deployment. These findings highlight significant ethical challenges that necessitate further investigation into the development of appropriate guidelines and regulatory frameworks for the clinical use of general-purpose AI models.

Indexed as

Artificial IntelligenceClinical Decision-MakingLanguagePatient SafetyHumansAI transparencyArtificial intelligence ethicsClinical decision supportHealthcare biasLarge Language modelsPatient safetyPrompt engineering

Identifiers

PMID41024005
PMCPMC12481957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.